Thromboelastography: Coagulation Beyond INR and aPTT
Dr. Dhanesh Sukumaran, Critical Care physician in Saveetha Medical College And Hospital, shared a very insightful post on Thromboelastography on LinkedIn:
”Understanding Coagulation Beyond INR and aPTT – The Power of TEG
In the ICU and OR, we often face complex coagulopathies—massive transfusions, sepsis-induced DIC, liver failure, trauma. Traditional labs like INR, aPTT, and platelet count tell only part of the story.
Enter Thromboelastography (TEG) – a dynamic, real-time assessment of the entire clotting cascade, from clot formation to lysis.
What makes TEG valuable?
- Rapid bedside results
- Guides goal-directed transfusion (PRBC, FFP, platelets, cryo, antifibrinolytics)
- Reduces unnecessary blood product use
- Especially useful in trauma, cardiac surgery, liver transplantation, and sepsis-related coagulopathy
Key parameters:
• R-time: Time to clot initiation (think clotting factors)
• K-time and Alpha angle: Speed of clot formation (fibrinogen function)
• MA (Maximum Amplitude): Strength of the clot (platelet function)
• LY30: Clot stability and fibrinolysis
TEG doesn’t replace conventional tests but complements them—giving us the “big picture” in real time.
If you’re not using TEG in your critical care or perioperative practice yet, it’s time to explore its impact.”
Find more comprehensive insights on coagulation in Hemostasis Today.
-
Jul 20, 2025, 16:435 Reasons LD May Outperform EVD in aSAH: Is Lumbar Drainage the Superior Strategy?
-
Jul 18, 2025, 12:18NBCA Hosts PEP Talk with Dr. Parks on Aging and Blood Clots
-
Jul 18, 2025, 12:14WFH Shares Powerful Patient Story on Access to Bleeding Disorders Treatment
-
Jul 18, 2025, 11:53HTRS Shines Spotlight on Faculty Powering the Future of Hemostasis and Thrombosis
-
Jul 16, 2025, 17:23ISTH 2025 Spotlight: HOPE-B Trial Highlights Sustained Efficacy of Gene Therapy for Hemophilia B
-
Jul 20, 2025, 17:12Thromboelastography: Coagulation Beyond INR and aPTT
-
Jul 20, 2025, 16:555 Crucial Insights into Low VWF QL: Uncovering a Distinct Cause of Bleeding
-
Jul 19, 2025, 17:16Promising 85% Response: Ru-D Regimen Shows Hope for Adults with HLH
-
Jul 19, 2025, 16:16A Potential Link to Recurrent Pregnancy Loss: Monoclonal Anti-PF4 Antibodies' Role
-
Jul 19, 2025, 15:2115% Recanalization Rate During Transfer in Basilar Artery Occlusion: A Missed Opportunity?
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 20, 2025, 17:17Michael Makris Shares 2 Fascinating Lessons from Hemophilia Care in Japan
-
Jul 16, 2025, 10:24Salma Ismail: Honored to Be Invited By the EHA2025 as Part of Their Lighting the Flame Program
-
Jul 15, 2025, 17:002022 Chemistry Laureate Carolyn Bertozzi Shares Inspiring Advice for Young Scientists
-
Jul 15, 2025, 16:42A 200+ Year Historical Review of Women and Hemophilia: Shifting Perspectives
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy